Found 5 matching trials
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours NA This study is a single arm, open design aimed at evaluating the safety and ...
Show More Location
Beijing Arion Cancer Center
Learn More & Join Trial
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours NA This study is a single arm, open design aimed at evaluating the safety and ...
Show More Location
Obstetrics & Gynecology Hospital of Fudan University
Learn More & Join Trial
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer NA This study is a single arm, open design aimed at evaluating the safety and ...
Show More Location
Shanghai Jiaotong University School of Medcine, Renji Hospital
Learn More & Join Trial
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors NA This study adopts a single-center, single-arm, open-label design. It aims t...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors EARLY_PHASE1 This study is an early exploration clinical study with one arm. The study c...
Show More Location
Shanghai Jiaotong University School of Medcine, Renji Hospital Ethica Committee
Learn More & Join Trial